<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346888</article-id>
      <article-id pub-id-type="pmc">3875999</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132248</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Phacomatosis pigmentovascularis type IIa - Case report<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Facomatose pigmentovascular tipo IIa - relato de caso</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Segatto</surname>
            <given-names>Majori&#xEA; Mergen</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schmitt</surname>
            <given-names>Elo&#xED;sa Unfer</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hagemann</surname>
            <given-names>Laura Netto</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>da Silva</surname>
            <given-names>Roberta Castilhos</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cattani</surname>
            <given-names>Cristiane Almeida Soares</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD, Dermatologist, graduate student in Pathology at the Federal
University for Health Sciences (Universidade Federal de Ci&#xEA;ncias da Sa&#xFA;de de Porto
Alegre - UFCSPA) - Porto Alegre (RS), Brazil.</aff>
      <aff id="aff02"><label>2</label> MD, Resident doctor in Dermatology at Sanitary Dermatology Outpatient
Clinic (Ambulat&#xF3;rio de Dermatologia Sanit&#xE1;ria - ADS) - Porto Alegre (RS), Brazil.</aff>
      <aff id="aff03"><label>3</label> MD, Dermatologist, Preceptor of Medical Residency at Sanitary
Dermatology Outpatient Clinic (Ambulat&#xF3;rio de Dermatologia Sanit&#xE1;ria -ADS) - Porto
Alegre (RS), Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Majori&#xEA; Mergen Segatto, Av. Getulio Vargas 901/1303 -
Menino Deus, 90150-003 - Porto Alegre - RS, Brazil. E-mail:
<email>msegatto@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>85</fpage>
      <lpage>88</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>11</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>2</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Phacomatosis Pigmentovascularis is a rare syndrome characterized by capillary
malformation and pigmentary nevus. A case of a 2-year-old patient is reported, who
presented extensive nevus flammeus and an aberrant Mongolian spot, without systemic
disease, manifestations that allow us to classify this case as type IIa Phacomatosis
Pigmentovascularis, according to Hasegawa's classification.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>A Facomatose Pigmentovascular, s&#xED;ndrome rara, &#xE9; caracterizada pela presen&#xE7;a
concomitante de malforma&#xE7;&#xE3;o capilar e nevos pigmentares. Relata-se o caso de um
paciente de dois anos de idade com malforma&#xE7;&#xE3;o capilar extensa e mancha mong&#xF3;lica
aberrante sem comprometimento sist&#xEA;mico, manifesta&#xE7;&#xF5;es que o incluem no tipo IIa na
classifica&#xE7;&#xE3;o da Facomatose Pigmentovascular, segundo Hasegawa.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Hemangioma</kwd>
        <kwd>Nevus of Ota</kwd>
        <kwd>Nevus, pigmented</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Phacomatosis Pigmentovascularis (PPV) represents a rare cutaneous congenital
malformation syndrome, characterized mainly by the presence of capillary malformation
and pigmentary nevi.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> Around 245 cases
have been published since it was described in 1947. The present case describes a patient
with type IIa Phacomatosis Pigmentovascularis or cesioflammea. </p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>We evaluated a male patient, 2 years and 5 months old, white, born full-term through
vaginal delivery, weighing 3330g. Apgar score was 9 at first and fifth minutes. He
presented since birth erythema-to-violaceous spots on the face, anterior trunk and upper
and lower limbs that did not stop at midline (<xref ref-type="fig" rid="f01">Figures
1</xref> and <xref ref-type="fig" rid="f02">2</xref>). Moreover, aberrant Mongolian
spots on the back, abdomen, buttocks and lower limbs (<xref ref-type="fig" rid="f03">Figures 3</xref> and <xref ref-type="fig" rid="f04">4</xref>) were noted. The
lesions were asymptomatic and did not change over time.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Bilateral erythemato-violaceous spots on the face</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0085-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Erythemato-violaceous spots on hand and right forearm</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0085-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Aberrant Mongolian spot on the dorsum</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0085-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Mongolian spot on buttocks</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0085-g04"/>
      </fig>
      <p>The child was not suffering from chronic diseases and there was no history of parental
consanguinity or similar cases in the family. He was not taking any medication. During
the exam no alterations in the neuropsychomotor development were observed and the
extremities were symmetrical, without atrophy or hypertrophy signs in the soft tissues. </p>
      <p>The opthalmic exam revealed Nevus of Ota on the left, without criteria for diagnosis of
glaucoma or other anomalies (<xref ref-type="fig" rid="f05">Figure 5</xref>). Laboratory
exams were normal. Furthermore, bilateral head and orbital magnetic resonance imaging,
total abdominal ultrasonography, electroencephalogram during sleep and vigil and
echocardiogram did not show alterations. </p>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Nevus of Ota</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0085-g05"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Phacomatosis Pigmentovascularis was first described by Ota, in 1947, as an association
of dermal melanocytosis with congenital vascular nevi, mainly capillary
malformation.<sup><xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
      <p>It was classified by Hasegawa and Yasuhara into four types according to the pigmentary
lesion associated with nevus flammeus and in 2003 a fifth type was described,
characterized by cutis marmorata telangiectatica and dermal melanocytosis.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref></sup>
Each type was further subdivided according to the presence of cutaneous-only
manifestations (subtype a) or if associated to systemic manifestations (subtype b), the
majority of which are ocular, vascular, skeletal and neurological.<sup><xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>In 2005, Happle proposed a new simplified classification into four groups, utilizing
descriptive terms: Phacomatosis Cesioflamea (association of the nevus flameus and
aberrant Mongolian spots or blue nevus); Phacomatosis Spilorosea (coexistence of Nevus
Spilus and telangiectatic nevus, which for Happle is different than nevus flameus);
Phacomatosis Cesiomarmorata (association of aberrant Mongolian spots or blue nevus with
Cutis Marmorata Telangiectatica Congenita) and Phacomatosis Pigmentovascularis of
non-classifiable type.<sup><xref ref-type="bibr" rid="r06">6</xref></sup> On this last
classification, there is no subdivision between presentation with or without systemic
symptoms. <xref ref-type="table" rid="t01">Chart 1</xref> synthesizes the two
classifications. </p>
      <table-wrap id="t01" orientation="portrait" position="float">
        <label>CHART 1</label>
        <caption>
          <p>Information about PPV classifications</p>
        </caption>
        <table frame="box" rules="groups">
          <thead>
            <tr>
              <td align="center" rowspan="1" colspan="1">
<bold>Type </bold>
</td>
              <td align="center" rowspan="1" colspan="1">
<bold>Type </bold>
</td>
              <td rowspan="1" colspan="1">
<bold>Vascular lesion </bold>
</td>
              <td rowspan="1" colspan="1">
<bold>Pigmentary lesion </bold>
</td>
            </tr>
            <tr>
              <td align="center" rowspan="1" colspan="1">
<bold>(according to Happle)</bold>
</td>
              <td align="center" rowspan="1" colspan="1">
<bold>(according to Hasegawa<xref ref-type="table-fn" rid="t01-fn01">*</xref>)</bold>
</td>
              <td rowspan="1" colspan="1">&#xA0;</td>
              <td rowspan="1" colspan="1">&#xA0;</td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">(inexistent<xref ref-type="table-fn" rid="t01-fn02">**</xref>) </td>
              <td align="center" rowspan="1" colspan="1">I</td>
              <td rowspan="1" colspan="1">Nevus flammeus </td>
              <td rowspan="1" colspan="1">Verrucous and pigmented nevus </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Cesioflammea </td>
              <td align="center" rowspan="1" colspan="1">II </td>
              <td rowspan="1" colspan="1">Nevus flammeus &#xB1; anemic nevus </td>
              <td rowspan="1" colspan="1">Mongolian spot </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Spilorosea </td>
              <td align="center" rowspan="1" colspan="1">III </td>
              <td rowspan="1" colspan="1">Nevus flammeus &#xB1; anemic nevus </td>
              <td rowspan="1" colspan="1">Nevus Spilus </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Non-classifiable </td>
              <td align="center" rowspan="1" colspan="1">IV </td>
              <td rowspan="1" colspan="1">Nevus flammeus &#xB1; anemic nevus </td>
              <td rowspan="1" colspan="1">Mongolian spot, Nevus Spilus </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Cesiomarmorata </td>
              <td align="center" rowspan="1" colspan="1">V </td>
              <td rowspan="1" colspan="1">Cutis Marmorata Telangiectatica Congenita </td>
              <td rowspan="1" colspan="1">Mongolian spot </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t01-fn01">
            <p>* All subtypes, according to Hasegawa, are subdivided in types <bold>(a)</bold>
or <bold>(b)</bold> - with and without systemic involvement, respectively</p>
          </fn>
          <fn id="t01-fn02">
            <p>** According to Happle, the subtype I does not exist for there are no reported
cases to this day</p>
          </fn>
          <fn>
            <p>
<bold>Source:</bold> Happle R. 2005<sup><xref ref-type="bibr" rid="r06">6</xref></sup> e Hasegawa Y, <italic>et al</italic>. 1985.<sup><xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Until now, about 245 cases have been reported, the majority on Oriental patients. Type
II is the most frequently found, related or not to systemic symptoms. The most common
association with extra cutaneous presentations is with the Sturge-Weber syndrome and
with the Klippel-Tr&#xE9;nauney syndrome, individually or combined.<sup><xref ref-type="bibr" rid="r07">7</xref></sup>
</p>
      <p>In 2008, the Fern&#xE1;ndez-Guarino revision showed that 77% of the 222 cases of PPV
described until then were of type II or cesioflammea, of which around 60% presented
systemic involvement. Series of 15 PPV cases presented similar percentages to previous
series regarding the distribution of presentations.<sup><xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>The pathogenesis of PPV is not fully known yet, but it is believed to be an abnormality
in the development of melanocytic nevus cells and vasomotor neural cells derived from
the neural crest.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> The best accepted
genetic model to explain PPV is didymosis (twin spots), a well known phenomenon in
plants and animals. Didymosis is characterized by two areas of adjacent cutaneous
lesions, formed by mutant tissues which also differ from the normal surrounding tissue. </p>
      <p>Dermal melanocytoses occur when fetal melanocytes present a migration failure, from the
neural crest to the dermal basal layer. There are five types, the Mongolian spot being
the most frequent, followed by blue nevus and Nevus of Ota. In Brazil, the Mongolian
spot has an estimated prevalence of 65% in blacks and 52% in mixed ethnicities. The
pattern of inheritance is autosomal dominant and it is located on the lumbar and gluteal
areas, disappearing with age. It is considered aberrant when it is on an ectopic site
(dorsum, shoulders, extremities and face). In this case, it is generally extensive, may
involve over 50% of body surface and does not disappear with age. The Nevus of Ota and
the Nevus of Ito can be considered aberrant Mongolian spots<sup><xref ref-type="bibr" rid="r08">8</xref></sup>
</p>
      <p>The vascular component is usually extensive in PPV patients and, when compared with
other capillary malformations, there are histopathological differences, like the
presence of vasomotor neural cells and prominent endothelial cells.<sup><xref ref-type="bibr" rid="r08">8</xref></sup>
</p>
      <p>The case reported presents manifestations that classify it as type IIa, that is,
extensive bilateral lesions of capillary malformation and aberrant Mongolian spots. To
this day, the patient has not presented systemic involvement. However, the importance of
follow-up should be emphasized, since systemic alterations can become evident with time,
changing the classification and prognosis. </p>
      <p>PPV without systemic involvement has a benign course e does not require treatment.
Nonetheless, due to the aesthetic impact, some procedures have been considered in order
to enhance the quality of life of PPV patients, using pulsed laser light for treatment
of nevus flammeus and Q-switched laser for treatment of pigmented nevi. The exact moment
for the intervention has also been discussed. Today it is suggested that the combined
laser treatment should be done in childhood, preferably before school age, to diminish
the extension of lesions to be treated and their effect on the self-esteem of
patients.<sup><xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Work performed at Sanitary Dermatology Outpatient Clinic (ADS)- Secretariat of
Health - Porto Alegre (RS), Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES </title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>An infant with extensive Mongolian spot, naevus flammeus and cutis
marmorata telangiectatica congenita: a unique case of phakomatosis
pigmentovascularis</article-title>
          <source>Br J Dermatol</source>
          <year>2007</year>
          <volume>156</volume>
          <fpage>1068</fpage>
          <lpage>1071</lpage>
          <pub-id pub-id-type="pmid">17355231</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ota</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kawarnura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Phakomatosis pigmentovascularis</article-title>
          <source>Jpn J Dermatol B</source>
          <year>1947</year>
          <volume>57</volume>
          <fpage>1</fpage>
          <lpage>3</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hasegawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yasuhara</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Phakomatosis pigmentovascularis type VIa</article-title>
          <source>Arch Dermatol</source>
          <year>1985</year>
          <volume>121</volume>
          <fpage>651</fpage>
          <lpage>655</lpage>
          <pub-id pub-id-type="pmid">3994413</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Torrelo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zambrano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Happle</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Cutis marmorata telangiectasica congenita and extensive Mongolian
spots: type V phakomatosis pigmentovascularis</article-title>
          <source>Br J Dermatol</source>
          <year>2003</year>
          <volume>148</volume>
          <fpage>342</fpage>
          <lpage>345</lpage>
          <pub-id pub-id-type="pmid">12588390</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fern&#xE1;ndez-Guarino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Boixeda</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>de Las Heras</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Aboin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Garc&#xED;a-Mill&#xE1;n</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Olasolo</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Phakomatosis pigmentovascularis: Clinical findings in 15 patients and
review of the literature</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2008</year>
          <volume>58</volume>
          <fpage>88</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">18045734</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Happle</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Phakomatosis pigmentovascularis revisited and
reclassified</article-title>
          <source>Arch Dermatol</source>
          <year>2005</year>
          <volume>141</volume>
          <fpage>385</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="pmid">15781681</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finklea</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Mohr</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Warthan</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Darrow</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>JV</given-names>
            </name>
          </person-group>
          <article-title>Two reports of phacomatosis pigmentovascularis type IIb, one in
association with Sturge-Weber Syndrome and Klippel-Trenaunay
Syndrome</article-title>
          <source>Pediatr Dermatol</source>
          <year>2010</year>
          <volume>27</volume>
          <fpage>303</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="pmid">20609155</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ribas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ribas</surname>
              <given-names>CBR</given-names>
            </name>
            <name>
              <surname>Schettini</surname>
              <given-names>APM</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Facomatose Pigmentovascular: relato de
caso</article-title>
          <source>An Bras Dermatol</source>
          <year>1997</year>
          <volume>72</volume>
          <fpage>163</fpage>
          <lpage>166</lpage>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kono</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Er&#xE7;&#xF6;&#xE7;en</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Kikuchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hori</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Uezono</surname>
              <given-names>S</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Treatment of Phacomatosis Pigmentovascularis: A Combined Multiple
Laser Approach</article-title>
          <source>Dermatol Surg</source>
          <year>2003</year>
          <volume>29</volume>
          <fpage>642</fpage>
          <lpage>646</lpage>
          <pub-id pub-id-type="pmid">12786710</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
